Another Gene Therapy Death; Biopharma M&A Picks Up; a Vaccine Board of Vaccine Skeptics

Retrieved on: 2025-06-18 10:31:35

Tags for this article:

Click the tags to see associated articles and topics

Another Gene Therapy Death; Biopharma M&A Picks Up; a Vaccine Board of Vaccine Skeptics. View article details on hiswai:

Excerpt

BioNTech also got in on the dealmaking, buying its German rival—scientifically and in the courtroom—CureVac for about $1.25 billion. The deal ...

Article found on: www.biospace.com